ALEMS Stock Overview
Engages in the design, development, and manufacturing of medical imaging systems for digital radiology and bone densitometry in Belgium. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
European Medical Solutions Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.018 |
| 52 Week High | €0.037 |
| 52 Week Low | €0.0024 |
| Beta | 0.57 |
| 1 Month Change | -5.26% |
| 3 Month Change | -7.22% |
| 1 Year Change | -18.18% |
| 3 Year Change | -91.67% |
| 5 Year Change | -94.23% |
| Change since IPO | -99.73% |
Recent News & Updates
Does European Medical Solutions (EBR:ALEMS) Have A Healthy Balance Sheet?
Dec 13
Would DMS Imaging (EBR:ALIMG) Be Better Off With Less Debt?
Jun 15DMS Imaging SA (EBR:ALIMG) Soars 29% But It's A Story Of Risk Vs Reward
Dec 21Recent updates
Does European Medical Solutions (EBR:ALEMS) Have A Healthy Balance Sheet?
Dec 13Would DMS Imaging (EBR:ALIMG) Be Better Off With Less Debt?
Jun 15DMS Imaging SA (EBR:ALIMG) Soars 29% But It's A Story Of Risk Vs Reward
Dec 21DMS Imaging SA's (EBR:DMSIM) Subdued P/S Might Signal An Opportunity
Jun 15Here's Why DMS Imaging (EBR:DMSIM) Can Manage Its Debt Responsibly
Dec 29Shareholder Returns
| ALEMS | BE Biotechs | BE Market | |
|---|---|---|---|
| 7D | -2.2% | -0.5% | -0.2% |
| 1Y | -18.2% | 10.4% | 0.05% |
Return vs Industry: ALEMS underperformed the Belgian Biotechs industry which returned 11.8% over the past year.
Return vs Market: ALEMS underperformed the Belgian Market which returned 0.6% over the past year.
Price Volatility
| ALEMS volatility | |
|---|---|
| ALEMS Average Weekly Movement | 5.6% |
| Biotechs Industry Average Movement | 7.5% |
| Market Average Movement | 3.7% |
| 10% most volatile stocks in BE Market | 6.7% |
| 10% least volatile stocks in BE Market | 2.1% |
Stable Share Price: ALEMS's share price has been volatile over the past 3 months compared to the Belgian market.
Volatility Over Time: ALEMS's weekly volatility has decreased from 11% to 6% over the past year, but is still higher than 75% of Belgian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1979 | 125 | Samuel Sancerni | www.dms-imaging.com |
European Medical Solutions engages in the design, development, and manufacturing of medical imaging systems for digital radiology and bone densitometry in Belgium. It offers R/F solutions, including PLATINUM NEO, a smart solution that revolutionizes the R/F workflow, as well as OPTIMA dRF, a robust solution; bone densitometry and body composition analysis equipment; chest and bone rooms, such as floor and ceiling tube stands; ambulatory radiography equipment; retrofit kits; C-ARM mobile operating room solutions; and mammography solutions. The company was formerly known as DMS Imaging SA and changed its name to European Medical Solutions in June 2024.
European Medical Solutions Fundamentals Summary
| ALEMS fundamental statistics | |
|---|---|
| Market cap | €26.81m |
| Earnings (TTM) | -€1.07m |
| Revenue (TTM) | €43.93m |
0.6x
P/S Ratio-25.0x
P/E RatioIs ALEMS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ALEMS income statement (TTM) | |
|---|---|
| Revenue | €43.93m |
| Cost of Revenue | €28.45m |
| Gross Profit | €15.48m |
| Other Expenses | €16.55m |
| Earnings | -€1.07m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.00072 |
| Gross Margin | 35.23% |
| Net Profit Margin | -2.44% |
| Debt/Equity Ratio | 133.4% |
How did ALEMS perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/25 12:54 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
European Medical Solutions is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Hugo Solvet | Bryan Garnier & Co |
| Andrew Smith | Edison Investment Research |
| Stephanie Lefebvre | Gilbert Dupont |